1-3 of 3
William Vaughan, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America

Christopher R. Flowers, MD, Michael Lill, M.D., Luciano J Costa, MD, PhD, Tsiporah B. Shore, William Vaughan, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, M.D., Mitchell E. Horwitz, MD, Joseph W. Fay, MD, Shin Mineishi, MD, Damiano Rondelli, MD, James Mason, MD, Vijay Reddy, MD, PhD, Ira Braunschweig, MD, Weiyun Ai, MD, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Cathy Zhao, PhD, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, Edmund K. Waller, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 768.
https://doi.org/10.1182/blood.V122.21.768.768
Published: 2013
Journal Articles

Safety of PK-Guided IV Bu Cy VP-16 Preparative Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: Findings From a Multi-Center Phase II Study in North America

Luciano J Costa, MD, PhD, Michael Lill, M.D., Rosa F. Yeh, PharmD, Robert K Stuart, MD, Stephen Lim, MD, Edmund K. Waller, MD, PhD, Tsiporah B. Shore, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, MD, Tulio E. Rodriguez, MD, Ian W. Flinn, MD, PhD, Terrance Comeau, MD, FRCPC, Michael A. Pulsipher, MD, Isabelle Bence-Bruckler, MD, FRCPC, Pierre Laneuville, MD, Philip Bierman, MD, Andy I. Chen, MD, PhD, Louie H. Yu, BS, Shiva Patil, PhD, Yiping Sun, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, William Vaughan, MD
Journal: Blood
Blood (2012) 120 (21): 813.
https://doi.org/10.1182/blood.V120.21.813.813
Published: 2012
Journal Articles

A Pilot Trial of Two Dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin, as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell Transplant (SCT) with Cyclosporine (CsA) as Graft Versus Host Disease (GvHD) Prophylaxis.

Kenneth B. Miller, MD, Nelson J. Chao, MD, Hans A. Messner, MD,PhD, Steven C. Goldstein, MD, Vijay Reddy, MD,PhD, William Vaughan, MD, Steven Devine, MD, Scott D. Rowley, MD, Ned Waller, MD,PhD, Marcel Devetten, MD, Gary J. Schiller, MD
Journal: Blood
Blood (2006) 108 (11): 5369.
https://doi.org/10.1182/blood.V108.11.5369.5369
Published: 2006